Clinical Trials Consulting and Training

AstraZeneca establishes scientific review board for clinical trial data transparency

Thursday, March 19, 2015

AstraZeneca has created a scientific review board that will act independently to assess requests from external researchers, which includes patient level data. The board of independent clinicians and academics has been established as part of AZ’s commitment to the European Federation of Pharmaceutical Industries and Associations (EFPIA) and Pharmaceutical Research and Manufacturers of America (PhRMA) Responsible Data Sharing Principles, as well as the new EMA Clinical Trial Policy and Regulation.

[Read More]